Please assess the completion status of the following clinical trial:

Trial Title: Mucinex Exploratory Cold Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* common cold symptoms~* meet symptom severity~* females of child-bearing potential must have negative pregnancy test and use effective birth control~Exclusion Criteria:~* chronic respiratory conditions~* significant heart, kidney, liver, or lung disease, uncontrolled hypertension or diabetes, cystic fibrosis, thyroid disorder~* pregnant or lactating~* known malignancy~* participation in any other clinical trial within 30 days of baseline~* related to another enrolled patient or persons involved directly or indirectly with the conduct of this study

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mucinex (Type: ACTIVE_COMPARATOR): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).